Native Tricuspid Valve Replacement
Notified Body #
Internal CECP dossier #
Date of reception of the dossier
Field of expert panel
Medical device type
The […] system is designed to replace the natice tricuspid valve. […] The […] valve consists of a trileaflet bovine pericardial tissue valve […] to be implanted in the native valve position.
The […] tricuspid valve replacement system is intended for the reduction of tricuspid regurgitation (TR) for patients who remain symptomatic on medical therapie and in whom no other surgical or transcatheter treatment option exists per heart team decision.